2026 年 5 月 22 日
Ready to start using GenAI in your medical and regulatory writing? Watch this webinar for everything you need to know.

Sean McGee, MS
Director of Product, CertaraSean McGee is currently the Director of Product at Certara, working within the Certara artificial intelligence (AI) group. Throughout his career, Mr. McGee has supported the strategy and go-to-market motions of various software technologies, including Benchling’s laboratory informatics platform and the AI and molecular modeling and simulation offerings for Dassault Systèmes BIOVIA brand. In his role with Certara, Mr. McGee guides the development of new AI-focused use cases which maximize the benefits of the Certara AI and broader company portfolio.
Mr. McGee completed his Master of Science at the University of Notre Dame exploring the scientific and commercial applications of medical devices designed to aid in the identification of child abuse.
1 https://openai.com/index/chatgpt/
2 https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/value-of-genai-in-pharma.html
3 https://www.bcg.com/press/24october2024-ai-adoption-in-2024-74-of-companies-struggle-to-achieve-and-scale-value
This blog was originally published in October 2025 and has been updated for accuracy.
常见问题解答
What are the biggest risks when using AI prompts in life sciences?
Because outputs may influence research, clinical decisions, or regulatory submissions, the main risks are hallucinations (incorrect claims), bias (misrepresentation of under-studied populations), and safety/regulatory noncompliance. Use constrained prompts, require citations, and set guardrails (e.g. “If uncertain, respond ‘I don’t know’” or “If nothing is found, respond with ‘None’”) to mitigate risk.
It is also important that, when AI is used in these and other critical areas, a human always reviews, checks, and verifies the response from the AI.
How do I evaluate if my prompt is “good enough” in scientific tasks?
You can assess prompts by metrics such as accuracy (correctness vs. reference), consistency (stable outputs across runs), reproducibility, and error rate (number of hallucinations). In critical tasks, maintain a “prompt testing dataset” of known inputs and expected outputs. Using this dataset, you can compare performance after changes to the prompt and underlying models.
Can I reuse prompts across life sciences subdomains (e.g. oncology, immunology)?
Yes – with caution. While many prompting principles are shared (clarity, providing examples, adding constraints), you’ll need to adapt the context, add domain-specific vocabulary, and modify or set additional constraints (e.g. safety thresholds, biomarker ranges). Always test the reuse of prompts on domain-specific validation cases to ensure reliability.
选择 CoAuthor™,体验监管写作的未来。
立即预约免费演示,亲睹 CoAuthor™ 如何革新您的监管写作流程。


